443 related articles for article (PubMed ID: 31055222)
1. An omega-3 fatty acid plasma index ≥4% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment.
Alfaddagh A; Elajami TK; Saleh M; Mohebali D; Bistrian BR; Welty FK
Atherosclerosis; 2019 Jun; 285():153-162. PubMed ID: 31055222
[TBL] [Abstract][Full Text] [Related]
2. Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
Alfaddagh A; Elajami TK; Ashfaque H; Saleh M; Bistrian BR; Welty FK
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246960
[TBL] [Abstract][Full Text] [Related]
3. Eicosapentaenoic and docosahexaenoic acid supplementation and coronary artery calcium progression in patients with coronary artery disease: A secondary analysis of a randomized trial.
Hariri E; Asbeutah AA; Malik A; Amangurbanova M; Chedid G; Daher R; Al Hammoud M; Welty FK
Atherosclerosis; 2023 Dec; 387():117388. PubMed ID: 38056242
[TBL] [Abstract][Full Text] [Related]
4. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B
Welty FK; Schulte F; Alfaddagh A; Elajami TK; Bistrian BR; Hardt M
FASEB J; 2021 Apr; 35(4):e21448. PubMed ID: 33749913
[TBL] [Abstract][Full Text] [Related]
5. Effect of Omega-3 Fatty Acids on Coronary Plaque Morphology - A Serial Computed Tomography Angiography Study.
Motoyama S; Nagahara Y; Sarai M; Kawai H; Miyajima K; Sato Y; Matsumoto R; Takahashi H; Naruse H; Ishii J; Ozaki Y; Izawa H
Circ J; 2022 Apr; 86(5):831-842. PubMed ID: 34776470
[TBL] [Abstract][Full Text] [Related]
6. Effect of Eicosapentaenoic Acid/Docosahexaenoic Acid on Coronary High-Intensity Plaques Detected Using Noncontrast T1-weighted Imaging: The AQUAMARINE EPA/DHA Randomized Study.
Nakao K; Noguchi T; Miura H; Asaumi Y; Morita Y; Takeuchi S; Matama H; Sawada K; Doi T; Hosoda H; Nakashima T; Honda S; Fujino M; Yoneda S; Kawakami S; Nagai T; Nishihira K; Kanaya T; Otsuka F; Nakanishi M; Kataoka Y; Tahara Y; Goto Y; Kusano K; Yamamoto H; Omae K; Ogawa H; Yasuda S
J Atheroscler Thromb; 2024 Feb; 31(2):122-134. PubMed ID: 37704431
[TBL] [Abstract][Full Text] [Related]
7. Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial.
Nakao K; Noguchi T; Asaumi Y; Morita Y; Kanaya T; Fujino M; Hosoda H; Yoneda S; Kawakami S; Nagai T; Nishihira K; Nakashima T; Kumasaka R; Arakawa T; Otsuka F; Nakanishi M; Kataoka Y; Tahara Y; Goto Y; Yamamoto H; Hamasaki T; Yasuda S
Trials; 2018 Jan; 19(1):12. PubMed ID: 29310688
[TBL] [Abstract][Full Text] [Related]
8. Association between serum levels of n-3 polyunsaturated fatty acids and coronary plaque detected by coronary computed tomography angiography in patients receiving statin therapy.
Urabe Y; Yamamoto H; Kitagawa T; Utsunomiya H; Tsushima H; Tatsugami F; Awai K; Kihara Y
Circ J; 2013; 77(10):2578-85. PubMed ID: 23863750
[TBL] [Abstract][Full Text] [Related]
9. Effects of statins on serum n-3 to n-6 polyunsaturated fatty acid ratios in patients with coronary artery disease.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Michishita I
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):320-6. PubMed ID: 23324995
[TBL] [Abstract][Full Text] [Related]
10. Low serum docosahexaenoic acid is associated with progression of coronary atherosclerosis in statin-treated patients with diabetes mellitus: results of the treatment with statin on atheroma regression evaluated by intravascular ultrasound with virtual histology (TRUTH) study.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I
Cardiovasc Diabetol; 2014 Jan; 13():13. PubMed ID: 24410834
[TBL] [Abstract][Full Text] [Related]
11. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results.
Budoff MJ; Muhlestein JB; Bhatt DL; Le Pa VT; May HT; Shaikh K; Shekar C; Kinninger A; Lakshmanan S; Roy SK; Tayek J; Nelson JR
Cardiovasc Res; 2021 Mar; 117(4):1070-1077. PubMed ID: 32609331
[TBL] [Abstract][Full Text] [Related]
12. Effects of Fatty Acid Therapy in Addition to Strong Statin on Coronary Plaques in Acute Coronary Syndrome: An Optical Coherence Tomography Study.
Kita Y; Watanabe M; Kamon D; Ueda T; Soeda T; Okayama S; Ishigami K; Kawata H; Horii M; Inoue F; Doi N; Okura H; Uemura S; Saito Y
J Am Heart Assoc; 2020 Aug; 9(16):e015593. PubMed ID: 32805184
[TBL] [Abstract][Full Text] [Related]
13. Effects of serum n-3 to n-6 polyunsaturated fatty acids ratios on coronary atherosclerosis in statin-treated patients with coronary artery disease.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I
Am J Cardiol; 2013 Jan; 111(1):6-11. PubMed ID: 23040588
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
15. Omega-3/omega-6 fatty acid ratios in different phospholipid classes and depressive symptoms in coronary artery disease patients.
Mazereeuw G; Herrmann N; Ma DWL; Hillyer LM; Oh PI; Lanctôt KL
Brain Behav Immun; 2016 Mar; 53():54-58. PubMed ID: 26697998
[TBL] [Abstract][Full Text] [Related]
16. Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome.
Yagi S; Kondo D; Ise T; Fukuda D; Yamaguchi K; Wakatsuki T; Kawabata Y; Ito H; Saijo Y; Seno H; Sutou K; Ueno R; Todoroki T; Kusunose K; Matsuura T; Tobiume T; Yamada H; Soeki T; Shimabukuro M; Aihara KI; Akaike M; Sata M
J Atheroscler Thromb; 2019 Mar; 26(3):272-281. PubMed ID: 30135329
[TBL] [Abstract][Full Text] [Related]
17. The ratio of serum n-3 to n-6 polyunsaturated fatty acids is associated with diabetes mellitus in patients with prior myocardial infarction: a multicenter cross-sectional study.
Takahashi M; Ando J; Shimada K; Nishizaki Y; Tani S; Ogawa T; Yamamoto M; Nagao K; Hirayama A; Yoshimura M; Daida H; Nagai R; Komuro I
BMC Cardiovasc Disord; 2017 Jan; 17(1):41. PubMed ID: 28125968
[TBL] [Abstract][Full Text] [Related]
18. Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.
Elajami TK; Alfaddagh A; Lakshminarayan D; Soliman M; Chandnani M; Welty FK
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710178
[TBL] [Abstract][Full Text] [Related]
19. Correlation of omega-3 levels in serum phospholipid from 2053 human blood samples with key fatty acid ratios.
Holub BJ; Wlodek M; Rowe W; Piekarski J
Nutr J; 2009 Dec; 8():58. PubMed ID: 20034401
[TBL] [Abstract][Full Text] [Related]
20. The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides.
Schwellenbach LJ; Olson KL; McConnell KJ; Stolcpart RS; Nash JD; Merenich JA;
J Am Coll Nutr; 2006 Dec; 25(6):480-5. PubMed ID: 17229894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
